The same gastrointestinal side effects, central adaptations, and pleiotropic actions that once discouraged development are now recognized as manageable features of peptide pharmacology when appropriately contextualized
Link between insulin resistance and obesity-from diagnosis to treatment
Taking semaglutide long-term may not be a fit for individuals with certain health conditions or those who experience severe side effects
Dosing considerations for people with type 2 diabetes include closer monitoring of blood glucose, especially during dose escalation
Weight loss tablets could help remove a major psychological barrier for people who are interested in treatment but feel intimidated by injections
Aizawa S, Ookawa K, Kudo T, Asano J, Hayakari M, Tsuchida S